Companies: 10,795·Total market cap: $144.5T
Lantern Pharma Inc.

Lantern Pharma Inc.

LTRNNASDAQHealthcare● Active
$4.14
+$0.39(+10.27%)
Market Cap$52757936
P/E Ratio—
52W High$5.744
52W Low$1.11
ForecastMarket CapPE Ratio

Lantern Pharma Inc.（LTRN）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ltrn · 股价预测 · 3 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 3 位华尔街分析师

SellBuy

Buy

3 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
合计: 3 · 买入占比: 66.7%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.75

Lantern Pharma Inc.（LTRN）的分析师共识为 Buy，基于过去 3 个月内 3 位华尔街分析师的评级。LTRN 的 12 个月平均目标价为 $0.00，相对当前价 $3.75 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$3.94↑ 5.00%

1-day model range: $3.88–$3.99. Peak: $3.99 (+5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$3-28.5%
2028$2-38.6%
2029$2-43.0%
2030$2-45.0%
2031—-46.0%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)67.0Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · LTRN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$3.65BUY
MA 10$3.58BUY
MA 20$3.24BUY
MA 50$2.54BUY
MA 100$2.67BUY
MA 200$3.25BUY
Current $LTRN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.66BUY
EMA 10$3.55BUY
EMA 20$3.28BUY
EMA 50$2.88BUY
EMA 100$2.85BUY
EMA 200$3.09BUY
Current $LTRN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
EF Hutton2023-08-10
Maintains
Buy→Buy
EF Hutton2023-06-26
Maintains
Buy→Buy
HC Wainwright & Co.2023-05-18
Maintains
Neutral→Neutral
EF Hutton2023-03-21
Maintains
Buy→Buy
EF Hutton2023-02-15
Maintains
Buy→Buy
EF Hutton2022-11-01
Maintains
Buy→Buy
HC Wainwright & Co.2022-03-11
Maintains
Buy→Buy
HC Wainwright & Co.2021-11-02
Maintains
Buy→Buy
HC Wainwright & Co.2021-10-07
Maintains
Buy→Buy
Colliers Securities2020-07-28
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Lantern Pharma Inc. (LTRN) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover LTRN.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

LTRN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$2M

↓ 94.2% YoY

Revenue Next Year

$15M

↑ 648.7% YoY

EPS This Year

$-1.51

EPS Next Year

$-2.02

↑ 33.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LTRN EPS of $-1.51 for the current fiscal year, based on estimates from 1 analysts. The LTRN revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LTRN 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LTRN 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

LTRN 的短期预测（明日）为 $3.94（+5.00%）。 LTRN 对 2027 年的股价预测均值为 $3。 LTRN 对 2030 年的预测区间为 $2–$2。

Lantern Pharma Inc. 在 NASDAQ 上市，代码 LTRN。LTRN 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

LTRN 预测 · 8 个问题

根据 3 位华尔街分析师，LTRN 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $3.75，隐含约 +0.0% 的上行空间。

LTRN 目标价LTRN 分析师目标价LTRN 12个月目标价目标价 LTRN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.